Novo Nordisk CEO Mike Doustdar says the company is aiming to capture around 15 million new patients when Medicare starts covering obesity treatments. Doustdar said he doesn't expect Medicare access to ...

The weight-loss drugs that kicked off America's GLP-1 craze are about to get a lot less expensive, though only certain customers will notice the savings. Novo Nordisk said it will slash list prices of ...

Novo Nordisk CEO Mike Doustdar has a plan to steer the company through what’s been described as a “show me” year. The Danish drugmaker kicked off 2026 with its explosive obesity pill launch, but ...

Weight loss treatments provider Novo Nordisk might have experienced a sharp stock decline after disappointing 2025 results and 2026 outlook, but it has seen an impressive bounce back since. While the ...

As Novo Nordisk’s hotly anticipated Wegovy pill gets off to the races in the U.S., the company is making sure to cover its supply bases overseas, too. Novo plans to invest in an expansion of its ...

Novo Nordisk's next diabetes/weight loss medicine should be better than its current crown jewel. The Danish drugmaker is still facing some challenges, but its pipeline could get it out of trouble. Can ...

Feb 11 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab said on Wednesday it plans to launch its weight-loss pill Wegovy in vials. "We are exploring various device presentations for Wegovy, ...

Novo Nordisk received final approval for a higher dose of its Wegovy weight-loss shot from the European Commission. Approval of the higher 7.2 milligram dose of Wegovy means that doctors in the EU can ...

Eli Lilly (LLY +0.70%) and Novo Nordisk (NVO 1.25%) have made headlines over the past few years for selling one of the world's most in-demand products: weight loss drugs. Lilly is the maker of ...

Cole Hocker set a new American indoor mile record with a time of 3:45.94. The 24-year-old runner broke the previous record held by Yared Nuguse. Hocker also broke the American record for the ...

Riley Chamberlain just led the fastest women’s mile in collegiate history. On Saturday at the David Hemery Valentine Invitational, the senior from Brigham Young University finished second in ...

Novo Nordisk NOVO.B6.03%increase; green up pointing triangle shares fell 16% after the Danish drugmaker said its next-generation obesity treatment failed to outperform Eli Lilly’s Zepbound in a ...